PT - JOURNAL ARTICLE AU - Xiumei Liu AU - Xueming Wang AU - Xiaoling Zhang AU - Ai hua Cao TI - Allergic diseases influence symptom severity and T lymphocyte subgroups of children with tic disorders AID - 10.1136/jim-2021-001788 DP - 2021 Dec 01 TA - Journal of Investigative Medicine PG - 1453--1457 VI - 69 IP - 8 4099 - http://hw-f5-jim.highwire.org/content/69/8/1453.short 4100 - http://hw-f5-jim.highwire.org/content/69/8/1453.full SO - J Investig Med2021 Dec 01; 69 AB - Tic disorders (TD) are childhood-onset neurological disorders. Immune system dysregulation has been postulated to play a role in TD, and its mechanisms likely involve dysfunctional neural-immune cross-talk, which ultimately leads to altered maturation of the brain pathways that control different TD clinical manifestations and behavioral and emotional damages. Clinical studies have demonstrated an association between TD and allergies and overactive immune responses at a systemic level. In this study, the Yale Global Tic Severity Scale was taken as a global measure of tic severity. Compared with the control group, the group of children with TD plus allergic diseases displayed significantly increased Yale total scores (p<0.05), which suggests that children with TD plus allergic diseases have heavier tic symptoms. Both motor and vocal tic scores are higher in the group of children with TD plus allergy compared with the control group. We counted immune cell subpopulations using FACS. T lymphocyte subset comparison of CD3, CD4, CD8, and CD4:CD8 expression ratios revealed that the level of CD3, CD4, and CD4:CD8 in children with TD plus allergic diseases was significantly lower than those of children with TD without allergic diseases. These differences were statistically significant (p<0.05) and suggest that children with TD plus allergic diseases have imbalanced T lymphocyte subsets. We concluded that allergy increased the severity of TD through an imbalance in cellular immunity. Studies need to be done to show whether treatment of allergic symptoms leads to a decrease in TD manifestations.The data used to support the findings of this study are available from the corresponding author on reasonable request.